Provided by Tiger Trade Technology Pte. Ltd.

Kodiak Sciences Inc.

91.08
-1.2600-1.36%
Pre-market: 90.45-0.6300-0.69%08:53 EDT
Volume:1.31M
Turnover:120.27M
Market Cap:5.70B
PE:-21.91
High:94.25
Open:91.74
Low:89.91
Close:92.34
52wk High:104.00
52wk Low:10.94
Shares:62.58M
Float Shares:36.99M
Volume Ratio:0.41
T/O Rate:3.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1571
EPS(LYR):-4.3220
ROE:-368.37%
ROA:-60.45%
PB:93.29
PE(LYR):-21.07

Loading ...

Kodiak Sciences - Zenkuda Bla Planned for Q4 2026 to Include Five Positive Phase 3 Studies

THOMSON REUTERS
·
Sep 28

Kodiak Sciences Inc. - Zenkuda and Tabirafusp-Ted Demonstrated Safety Consistent with Established Safety Profile of Aflibercept

THOMSON REUTERS
·
Sep 28

Stocks to Watch: Kodiak Sciences, Circle Internet Group

Dow Jones
·
Sep 26

Kodiak Sciences Shares Surge Ahead of Phase 3 Readout

Dow Jones
·
Sep 26

Kodiak Sciences Upcoming Data Could Support Upside, UBS Says

MT Newswires Live
·
Sep 25

Kodiak Sciences (KOD) Initiated with a Hold at Goldman Sachs

TIPRANKS
·
Sep 24

Kodiak Sciences Price Target Maintained with a $58.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 17

KPK Seizes Rp6 Billion in Silmy Karim Foreign Residence Permit Extortion Case

Tempo
·
Aug 30

Kodiak Sciences Advances ALTO Phase 3 Trial In Diabetic Eye Disease

TIPRANKS
·
Aug 22

Kodiak Sciences Price Target Maintained with a $58.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 17

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 15

Outlook Therapeutics Q3 Net Loss Narrows Slightly as Costs Drop

Reuters
·
Aug 14

Heart Drug Developer Atrium Therapeutics' Q2 Loss Widens as Expenses Rise

Reuters
·
Aug 14

Ensysce Biosciences Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 14

Kodiak Sciences Q2 Net Income USD -65.643 Million

Reuters
·
Aug 14

Kodiak Sciences Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Kodiak Sciences Q2 EPS $(1.05) Misses $(0.95) Estimate

Benzinga Earnings
·
Aug 14

Kodiak Sciences Q2 FY26 Net Loss Widens to $65.64 Million

Reuters
·
Aug 14

Kodiak Sciences Q2 Operating Income USD -66.838 Million

THOMSON REUTERS
·
Aug 14

Kodiak Sciences Says First Patients Enrolled in Late-Stage Diabetic Eye Disease Trial

MT Newswires Live
·
Aug 11